🔗 Visit the ClinicalTrials.gov page for NCT01502592
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. | J Leukoc Biol | 2013 | 1.90 |
| 2 | Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade. | Expert Rev Anticancer Ther | 2012 | 1.03 |
| 3 | T cell coinhibition and immunotherapy in human breast cancer. | Discov Med | 2012 | 0.85 |
| 4 | Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy. | Cancer Immunol Res | 2016 | 0.79 |
| 5 | Immune aspects of the breast tumor microenvironment. | Breast Cancer Manag | 2013 | 0.77 |
| 6 | New clinical advances in immunotherapy for the treatment of solid tumours. | Immunology | 2015 | 0.76 |
| 7 | Surgical immune interventions for solid malignancies. | Am J Surg | 2016 | 0.75 |
| 8 | Percutaneous image-guided ablation of breast tumors: an overview. | Semin Intervent Radiol | 2014 | 0.75 |